HK20588A - Crystalline benzenesulfonate salts of sultamicillin - Google Patents

Crystalline benzenesulfonate salts of sultamicillin Download PDF

Info

Publication number
HK20588A
HK20588A HK205/88A HK20588A HK20588A HK 20588 A HK20588 A HK 20588A HK 205/88 A HK205/88 A HK 205/88A HK 20588 A HK20588 A HK 20588A HK 20588 A HK20588 A HK 20588A
Authority
HK
Hong Kong
Prior art keywords
sultamicillin
crystalline
salts
salt
formula
Prior art date
Application number
HK205/88A
Other languages
German (de)
English (en)
French (fr)
Inventor
Wayne Ernest Barth
Vytautas John Jasys
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of HK20588A publication Critical patent/HK20588A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK205/88A 1982-04-23 1988-03-17 Crystalline benzenesulfonate salts of sultamicillin HK20588A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (1)

Publication Number Publication Date
HK20588A true HK20588A (en) 1988-03-25

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
HK205/88A HK20588A (en) 1982-04-23 1988-03-17 Crystalline benzenesulfonate salts of sultamicillin

Country Status (27)

Country Link
US (1) US4432987A (Direct)
EP (1) EP0092968B1 (Direct)
JP (1) JPS58201792A (Direct)
KR (1) KR860001279B1 (Direct)
AU (1) AU536854B2 (Direct)
CA (1) CA1187484A (Direct)
CS (1) CS235320B2 (Direct)
DD (1) DD209632A5 (Direct)
DE (1) DE3362502D1 (Direct)
DK (1) DK162168C (Direct)
EG (1) EG16412A (Direct)
ES (1) ES521728A0 (Direct)
FI (1) FI76092C (Direct)
GR (1) GR78582B (Direct)
HK (1) HK20588A (Direct)
HU (1) HU187068B (Direct)
IE (1) IE54628B1 (Direct)
IL (1) IL68453A (Direct)
NO (1) NO156202C (Direct)
NZ (1) NZ203988A (Direct)
PH (1) PH18035A (Direct)
PL (1) PL134978B1 (Direct)
PT (1) PT76587B (Direct)
SG (1) SG104087G (Direct)
SU (1) SU1138030A3 (Direct)
YU (1) YU43170B (Direct)
ZA (1) ZA832845B (Direct)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
WO1987002893A1 (en) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
DE69528166T2 (de) * 1994-05-02 2003-04-30 Shionogi & Co., Ltd. Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
UA78104C2 (en) 2002-08-29 2007-02-15 Taisho Pharmaceutical Co Ltd Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives
DE602004022643D1 (de) * 2003-03-27 2009-10-01 Basilea Pharmaceutica Ag Cephalosporin in kristalliner form
AU2004285533A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
WO2009024823A2 (en) 2007-08-22 2009-02-26 Astrazeneca Ab Oxadiazole derivatives as dgat inhibitors
EP2620432A3 (en) 2007-10-26 2013-12-18 The Regents Of the University of California Diarylhydantoin compounds
WO2010088331A1 (en) * 2009-01-30 2010-08-05 Glaxosmithkline Llc Crystalline n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
WO2011006061A1 (en) * 2009-07-10 2011-01-13 Evolva Sa Diyne compositions
AU2011218490B9 (en) * 2010-02-18 2014-12-18 Astrazeneca Ab Solid forms comprising a cyclopropyl amide derivative
RU2012139082A (ru) * 2010-02-18 2014-03-27 Астразенека Аб Способы получения производных циклопропиламида и связанных с ними промежуточных соединений
WO2014087972A1 (ja) * 2012-12-03 2014-06-12 株式会社カネカ 還元型補酵素ｑ10誘導体およびその製造方法
CN108484469A (zh) * 2013-09-05 2018-09-04 田边三菱制药株式会社 新型结晶性芳烷基胺化合物及其制造方法
UA119794C2 (uk) * 2014-10-21 2019-08-12 Аріад Фармасьютикалз, Інк. Кристалічна форма 5-хлор-n4-[2-(диметилфосфорил)феніл]-n2-{2-метокси-4-[4-(4-метилпіперазин-1-іл)піперидин-1-іл]}піримідин-2,4-діаміну
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
EP3390358B1 (en) * 2016-01-22 2020-09-23 Sandoz AG Crystalline eravacycline bis-hydrochloride
US10889577B2 (en) 2016-07-07 2021-01-12 Cyclerion Therapeutics, Inc. Solid forms of an sGC stimulator
WO2019089540A1 (en) * 2017-10-30 2019-05-09 Theracaine Llc Hydrophobic arenesulfonate salts
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD1071069S1 (en) 2019-02-13 2025-04-15 Hs Produkt D.O.O. Stippled textured body for a firearm or the like
USD994822S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD994821S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1077123S1 (en) 2019-02-13 2025-05-27 Hs Produkt D.O.O. Firearm sight
USD998740S1 (en) 2019-02-13 2023-09-12 Hs Produkt D.O.O. Firearm
USD1057880S1 (en) 2019-08-09 2025-01-14 Hs Produkt D.O.O. Pistol
US11957696B2 (en) * 2021-02-15 2024-04-16 Propella Therapeutics, Inc. Abiraterone prodrugs
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol
US20240239802A1 (en) * 2021-05-12 2024-07-18 Zhejiang Longcharm Bio-Tech Pharma. Co., Ltd. Crystal form of pyrrolopyrimidine compound and preparation method for crystal form
JP2024520897A (ja) * 2021-05-14 2024-05-27 グローバル ブラッド セラピューティクス インコーポレイテッド ヘモグロビン調節因子の固体形態
USD1069964S1 (en) 2021-11-03 2025-04-08 Hs Produkt D.O.O. Pistol slide
WO2023125700A1 (zh) * 2021-12-28 2023-07-06 南京明德新药研发有限公司 四氢环庚吲唑化合物的盐型、晶型
EP4525860A2 (en) * 2022-05-20 2025-03-26 Caamtech, Inc. Tryptamine derivatives
USD1057882S1 (en) 2022-08-29 2025-01-14 Springfield, Inc. Combined serrations for a firearm slide
USD1072997S1 (en) 2022-08-29 2025-04-29 Springfield, Inc. Firearm
USD1061781S1 (en) 2022-11-30 2025-02-11 Hs Produkt D.O.O. Pistol
ZAA202301171S (en) 2023-04-28 2024-09-25 Hs Produkt D O O Firearm
AU2024292586A1 (en) * 2023-07-17 2026-01-29 Kura Oncology, Inc. Crystalline forms of a menin inhibitor
WO2025016385A1 (en) * 2023-07-17 2025-01-23 Kura Oncology, Inc. Pharmaceutical compositions comprising a menin inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
ZA80796B (en) * 1979-02-13 1981-02-25 Leo Pharm Prod Ltd Chemical compounds
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PT76587A (en) 1983-05-01
NO156202B (no) 1987-05-04
CA1187484A (en) 1985-05-21
AU536854B2 (en) 1984-05-24
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
IE54628B1 (en) 1989-12-20
DE3362502D1 (en) 1986-04-17
EP0092968B1 (en) 1986-03-12
FI831392L (fi) 1983-10-24
DK101783A (da) 1983-10-24
FI831392A0 (fi) 1983-04-22
ZA832845B (en) 1984-11-28
IE830926L (en) 1983-10-23
YU90483A (en) 1986-04-30
IL68453A0 (en) 1983-07-31
DD209632A5 (de) 1984-05-16
HU187068B (en) 1985-11-28
DK162168B (da) 1991-09-23
SG104087G (en) 1988-07-15
ES8406075A1 (es) 1984-07-01
FI76092C (fi) 1988-09-09
PL241553A1 (en) 1983-11-21
PH18035A (en) 1985-03-06
KR860001279B1 (ko) 1986-09-05
JPH0119395B2 (Direct) 1989-04-11
IL68453A (en) 1986-08-31
DK101783D0 (da) 1983-02-28
SU1138030A3 (ru) 1985-01-30
YU43170B (en) 1989-04-30
JPS58201792A (ja) 1983-11-24
EP0092968A1 (en) 1983-11-02
KR840004437A (ko) 1984-10-15
ES521728A0 (es) 1984-07-01
NO156202C (no) 1987-08-19
CS235320B2 (en) 1985-05-15
EG16412A (en) 1989-03-30
DK162168C (da) 1992-03-02
US4432987A (en) 1984-02-21
AU1387183A (en) 1983-11-17
FI76092B (fi) 1988-05-31
PL134978B1 (en) 1985-09-30
PT76587B (en) 1986-02-27
GR78582B (Direct) 1984-09-27

Similar Documents

Publication Publication Date Title
EP0092968B1 (en) Crystalline benzenesulfonate salts of sultamicillin
KR870001982B1 (ko) 결정성 1,1-디옥소페니실라노일옥시 메틸 6-(D-α-아미노-α-페닐아세트아미도)페니실라네이트 토실레이트 수화물의 제조방법.
US3957764A (en) 6-aminopenicillanic acid derivatives
IE49880B1 (en) Penicillin derivatives
IE833045L (en) Crystalline cephem-acid addition salts
RU2051919C1 (ru) Соединения пенема и фармацевтическая композиция на их основе
US4053609A (en) Penicillins and processes for preparing the same
US3931405A (en) New penicillin esters and methods and compositions for treating infectious diseases
SU1015830A3 (ru) Способ получени сложных эфиров 6-амидинопенициллановых кислот или их аддитивных солей с кислотами и его вариант
IE51516B1 (en) 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
JPH06503805A (ja) ペネム化合物
US3997527A (en) Aminomethylarylmethylpenicillin derivatives
US3759898A (en) Synthesis of alpha-(carbo(5-indanyloxy)) benzylpenicillin
US3539562A (en) Alpha - amino - 2,4,6 - cycloheptatrienylmethylcephalosporins
US3258461A (en) Derivatives of cephalosporin c and related compounds and a method of the synthesis thereof
IE53857B1 (en) Antibacterial esters of beta-lactams, and processes and intermediates for their preparation
US3980793A (en) Carbonate esters of penicillins and compositions and methods for treatment of bacterial infections
US3474089A (en) Substituted adamantyl penicillins
US3835115A (en) Alpha-(substituted sulfonamido)arylmethylpenicillins
US3966710A (en) Aminomethylarylmethylpenicillin derivatives
GB2052483A (en) Crystalline cephalosporin salts
US3819600A (en) Alpha-carboxamido acyl derivatives of penicillin
US3542925A (en) 6-amino-penicillanic acid derivatives for control of gram positive bacterial infections
US4009160A (en) Aminomethylarylmethylpenicillin derivatives
KR850000474B1 (ko) 6β-[2-(2'-메틸페녹시카르보닐)-2-티엔-3'-일아세트아미도]페니실란산의 제조방법

Legal Events

Date Code Title Description
PE Patent expired